Clinically important deterioration in a mild-moderate COPD population

Area of Science:

• Pulmonary Medicine
• Chronic Obstructive Pulmonary Disease (COPD) Research
• Clinical Epidemiology

Background:

• Clinically Important Deterioration (CID) is a composite outcome measuring disease worsening in COPD.
• Previous studies focused on moderate-severe COPD populations.
• The predictive value of CID in mild-moderate COPD requires further investigation.

Purpose of the Study:

• To assess if Clinically Important Deterioration (CID) predicts disease worsening over 18 months in a population-based cohort of individuals with mild-moderate COPD.
• To examine the association between CID components and future COPD exacerbations and health status decline.

Main Methods:

• Utilized data from the Canadian Cohort Obstructive Lung disease (CanCOLD) study.
• Assessed participants for CID over 18 months and subsequent outcomes over the next 18 months.
• Employed logistic regression, Cox proportional hazards, and Poisson regression models to analyze associations between CID and outcomes like exacerbations, lung function (FEV1), and health status (SGRQ, CAT).

Main Results:

• 60% of participants (252/420) experienced CID.
• CID was associated with future moderate/severe exacerbations (though not statistically significant), worsening health status (CAT score), and dyspnea.
• Exacerbations and health status components (SGRQ, CAT) were more informative predictors of future health status decline than FEV1 decline.

Conclusions:

• CID components, particularly exacerbation history and health status, are valuable for predicting future outcomes in mild-moderate COPD.
• Clinical assessments should prioritize exacerbation history and health status over solely relying on airway obstruction severity.
• Adaptations to the current CID definition may be necessary for application in mild-moderate COPD populations.